Oliver Harzer

733 total citations
17 papers, 515 citations indexed

About

Oliver Harzer is a scholar working on Infectious Diseases, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Oliver Harzer has authored 17 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Clinical Biochemistry and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Oliver Harzer's work include SARS-CoV-2 and COVID-19 Research (6 papers), SARS-CoV-2 detection and testing (4 papers) and COVID-19 Clinical Research Studies (3 papers). Oliver Harzer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), SARS-CoV-2 detection and testing (4 papers) and COVID-19 Clinical Research Studies (3 papers). Oliver Harzer collaborates with scholars based in Germany, Austria and France. Oliver Harzer's co-authors include Andreas Pfützner, Michael Trautmann, R. Renner, Blair Wilson, Klaus Rave, Solomon S. Steiner, L Heinemann, M. Engelbach, T. Kunt and Thomas Först and has published in prestigious journals such as PLoS ONE, Diabetes Care and British Journal of Sports Medicine.

In The Last Decade

Oliver Harzer

16 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Harzer Germany 10 219 116 83 77 73 17 515
Ayşegül Atmaca Türkiye 14 201 0.9× 104 0.9× 20 0.2× 31 0.4× 66 0.9× 45 512
Mehmet Keskın Türkiye 13 204 0.9× 64 0.6× 81 1.0× 56 0.7× 82 1.1× 52 697
Ming‐Chun Kuo Taiwan 13 195 0.9× 114 1.0× 52 0.6× 15 0.2× 25 0.3× 28 460
Geneviève Boulet Canada 15 198 0.9× 101 0.9× 61 0.7× 76 1.0× 107 1.5× 31 542
Е. А. Трошина Russia 12 298 1.4× 120 1.0× 17 0.2× 49 0.6× 57 0.8× 243 662
Claudia Brufani Italy 19 403 1.8× 283 2.4× 56 0.7× 63 0.8× 172 2.4× 36 888
João Roberto de Sá Brazil 13 167 0.8× 213 1.8× 28 0.3× 81 1.1× 60 0.8× 62 504
Isabel Cardona Spain 13 137 0.6× 140 1.2× 35 0.4× 44 0.6× 27 0.4× 24 479
Yoram Ramot Israel 13 235 1.1× 97 0.8× 13 0.2× 12 0.2× 90 1.2× 22 478
Sarwono Waspadji Indonesia 13 192 0.9× 79 0.7× 39 0.5× 53 0.7× 34 0.5× 44 416

Countries citing papers authored by Oliver Harzer

Since Specialization
Citations

This map shows the geographic impact of Oliver Harzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Harzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Harzer more than expected).

Fields of papers citing papers by Oliver Harzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Harzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Harzer. The network helps show where Oliver Harzer may publish in the future.

Co-authorship network of co-authors of Oliver Harzer

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Harzer. A scholar is included among the top collaborators of Oliver Harzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Harzer. Oliver Harzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mack, Dietrich, et al.. (2022). The importance of effect sizes when comparing cycle threshold values of SARS-CoV-2 variants. PLoS ONE. 17(7). e0271808–e0271808.
2.
Rebholz, Heike, et al.. (2022). Longitudinal monitoring of SARS-CoV-2 spike protein-specific antibody responses in Lower Austria. PLoS ONE. 17(7). e0271382–e0271382. 3 indexed citations
3.
Ladage, Dennis, et al.. (2021). Persisting Antibody Response to SARS-CoV-2 in a Local Austrian Population. Frontiers in Medicine. 8. 653630–653630. 6 indexed citations
4.
Ladage, Dennis, et al.. (2021). SARS-CoV-2-Specific Antibody Prevalence and Symptoms in a Local Austrian Population. Frontiers in Medicine. 8. 632942–632942. 7 indexed citations
5.
Mack, Dietrich, et al.. (2021). Where have the enteric viruses gone? - Differential effects on frequent causes of infectious diarrhoea by SARS-CoV-2 pandemic lockdown measures. Infection Prevention in Practice. 3(4). 100184–100184. 12 indexed citations
6.
7.
Meyer, Tim, Dietrich Mack, Oliver Harzer, et al.. (2020). Successful return to professional men’s football (soccer) competition after the COVID-19 shutdown: a cohort study in the German Bundesliga. British Journal of Sports Medicine. 55(1). 62–66. 80 indexed citations
8.
Kriegsmann, Katharina, et al.. (2020). Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry. Viruses. 12(8). 849–849. 20 indexed citations
9.
Kunt, T., Thomas Först, Oliver Harzer, et al.. (2009). The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules. Experimental and Clinical Endocrinology & Diabetes. 106(3). 183–188. 16 indexed citations
10.
Kunt, T., Barbara Früh, Thomas Flohr, et al.. (2009). Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro. Experimental and Clinical Endocrinology & Diabetes. 107(4). 252–256. 13 indexed citations
11.
Kunt, T., Thomas Först, Christof Kazda, et al.. (2007). The β-Specific Protein Kinase C Inhibitor Ruboxistaurin (LY333531) Suppresses Glucose-Induced Adhesion of Human Monocytes to Endothelial Cells in Vitro. Journal of Diabetes Science and Technology. 1(6). 929–934. 6 indexed citations
12.
Steiner, Solomon S., Andreas Pfützner, Blair Wilson, et al.. (2002). TechnosphereTM/Insulin - proof of concept study with a new insulin formulation for pulmonary delivery. Experimental and Clinical Endocrinology & Diabetes. 110(1). 17–21. 89 indexed citations
13.
Kunt, T., Thomas Först, A Pfützner, et al.. (2000). Serum levels of substance P are decreased in patients with type 1 diabetes. Experimental and Clinical Endocrinology & Diabetes. 108(3). 164–167. 34 indexed citations
14.
Pfützner, A, Oliver Harzer, T. Kunt, et al.. (2000). Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus.. PubMed. 46(5-6). 275–9. 2 indexed citations
15.
Kunt, T., Thomas Först, Hans Tritschler, et al.. (1999). α-Lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products. Clinical Science. 96(1). 75–82. 70 indexed citations
16.
17.
Kunt, T., Thomas Först, P. Kann, et al.. (1998). Establishment of a quantitative RT-pCR for detection of vascular cell adhesion molecule-1 transcripts in endothelial cells after stimulation with advanced glycation endproducts.. International Journal of Molecular Medicine. 2(4). 455–60. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayşegül Atmaca Breakdown of academic impact, for papers by Mehmet Keskın Breakdown of academic impact, for papers by Ming‐Chun Kuo Breakdown of academic impact, for papers by Geneviève Boulet Breakdown of academic impact, for papers by Е. А. Трошина Breakdown of academic impact, for papers by Claudia Brufani Breakdown of academic impact, for papers by João Roberto de Sá Breakdown of academic impact, for papers by Isabel Cardona Breakdown of academic impact, for papers by Yoram Ramot Breakdown of academic impact, for papers by Sarwono Waspadji
Rankless by CCL
2026